Genichi Nishimura
Overview
Explore the profile of Genichi Nishimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishida H, Yamaguchi T, Tanakaya K, Akagi K, Inoue Y, Kumamoto K, et al.
J Anus Rectum Colon
. 2019 Nov;
2(Suppl I):S1-S51.
PMID: 31773066
Hereditary colorectal cancer accounts for less than 5% of all colorectal cancer cases. Some of the unique characteristics that are commonly encountered in cases of hereditary colorectal cancer include early...
2.
Suto T, Ishiguro M, Hamada C, Kunieda K, Masuko H, Kondo K, et al.
Int J Clin Oncol
. 2017 Jun;
22(4):805-806.
PMID: 28608229
No abstract available.
3.
Kotake M, Aoyama T, Munemoto Y, Doden K, Kataoka M, Kobayashi K, et al.
Oncol Lett
. 2017 Mar;
13(2):747-753.
PMID: 28356954
The current phase II study investigated the efficacy and safety of biweekly cetuximab combined with standard oxaliplatin-based chemotherapy [infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin (FOLFOX-6)] in the first-line treatment of...
4.
Watanabe T, Muro K, Ajioka Y, Hashiguchi Y, Ito Y, Saito Y, et al.
Int J Clin Oncol
. 2017 Mar;
23(1):1-34.
PMID: 28349281
Japanese mortality due to colorectal cancer is on the rise, surpassing 49,000 in 2015. Many new treatment methods have been developed during recent decades. The Japanese Society for Cancer of...
5.
Suto T, Ishiguro M, Hamada C, Kunieda K, Masuko H, Kondo K, et al.
Int J Clin Oncol
. 2017 Jan;
22(3):494-504.
PMID: 28078540
Background: Six months of adjuvant chemotherapy is regarded as the standard of care for patients with stage III colon cancer. However, whether longer treatment can improve prognosis has not been...
6.
Nishijima K, Nishimura G
Gan To Kagaku Ryoho
. 2016 Jan;
42(13):2430-3.
PMID: 26809301
Operative stress causes various changes in the body, and immunological hypofunction and malnutrition increase complications and adversely affect long-term prognosis. Therefore, reducing operative stress as much as possible, minimizing complications...
7.
Sadahiro S, Morita S, Sasaki K, Sakamoto K, Ohge H, Takahashi T, et al.
Clin Colorectal Cancer
. 2015 Jun;
14(4):277-80.
PMID: 26068602
Background: The usefulness of adjuvant chemotherapy for stage II colon cancer has not been established. Meanwhile, the presence of stage II colon cancer with high-risk factors for recurrence has been...
8.
Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al.
Int J Clin Oncol
. 2015 Mar;
20(2):207-39.
PMID: 25782566
Colorectal cancer is a major cause of death in Japan, where it accounts for the largest number of deaths from malignant neoplasms among women and the third largest number among...
9.
Shinto E, Takahashi K, Yamaguchi T, Hashiguchi Y, Kotake K, Itabashi M, et al.
Ann Surg Oncol
. 2015 Mar;
22(12):3888-95.
PMID: 25758188
Background: A Japanese multicenter study disclosed four prognostic indicators of colorectal cancer liver metastases: ≥5 hepatic tumors (HT), HT size > 5 cm, nodal status (N2) of primary cancer, and...
10.
Hashimoto M, Matsuzaki Y, Kawahara K, Matsuda H, Nishimura G, Hatae T, et al.
Biol Pharm Bull
. 2014 Jul;
37(7):1228-33.
PMID: 24989013
To assess the reasons for barriers to home discharge by determining whether they were predicted by medication, clinical variables, and patient characteristics, the retrospective cohort study of 282 patients discharged...